Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Total Liabilities (Quarterly): 107.68M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 107.68M |
| March 31, 2024 | 112.57M |
| December 31, 2023 | 102.93M |
| September 30, 2023 | 126.94M |
| June 30, 2023 | 127.92M |
| March 31, 2023 | 206.79M |
| December 31, 2022 | 202.16M |
| Date | Value |
|---|---|
| September 30, 2022 | 272.88M |
| June 30, 2022 | 279.19M |
| March 31, 2022 | 344.30M |
| December 31, 2021 | 314.71M |
| September 30, 2021 | 352.07M |
| June 30, 2021 | 47.45M |
| December 31, 2020 | 962.41M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
47.45M
Minimum
Jun 2021
962.41M
Maximum
Dec 2020
254.29M
Average
204.48M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Dentsply Sirona Inc | 4.136B |
| Ligand Pharmaceuticals Inc | 113.69M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 135.49M |
| Shareholders Equity (Quarterly) | 27.81M |
| Debt to Equity Ratio | 1.474 |
| Current Ratio | 0.2611 |
| Net Debt Paydown Yield | -1.55% |